Cargando…
Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
Despite the fast development of vaccines, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still circulates through variants of concern (VoC) and escape the humoral immune response. SARS-CoV-2 has provoked over 200,000 deaths/months since its emergence and only a few antiviral drugs...
Autores principales: | Chaves, Otávio Augusto, Lima, Carlyle Ribeiro, Fintelman-Rodrigues, Natalia, Sacramento, Carolina Q., de Freitas, Caroline S., Vazquez, Leonardo, Temerozo, Jairo R., Rocha, Marco E.N., Dias, Suelen S.G., Carels, Nicolas, Bozza, Patrícia T., Castro-Faria-Neto, Hugo Caire, Souza, Thiago Moreno L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525951/ https://www.ncbi.nlm.nih.gov/pubmed/36183752 http://dx.doi.org/10.1016/j.ijbiomac.2022.09.204 |
Ejemplares similares
-
In vitro antioxidant properties of the biflavonoid agathisflavone
por: Andrade, Anderson Wilbur Lopes, et al.
Publicado: (2018) -
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
por: Chaves, Otávio Augusto, et al.
Publicado: (2022) -
Fluorine Atoms on C(6)H(5)-Corrole Affect the Interaction with M(pro) and PL(pro) Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches
por: Chaves, Otávio Augusto, et al.
Publicado: (2022) -
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
por: Chaves, Otávio Augusto, et al.
Publicado: (2022) -
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
por: Fintelman-Rodrigues, Natalia, et al.
Publicado: (2020)